Aortic valve stenosis leads to dyspnoea, syncope, heart failure and limited life expectancy, 5-
year survival is only 15–50%[1]. For highrisk patients, transcatheter aortic valve implantation …

Aortic valve stenosis is a common heart valve disorder in adults. Its prevalence increases
with age and is therefore especially seen in older patients. Thirty to forty per cent of patients …

Patients with severe symptomatic aortic stenosis have a poor prognosis with medical
management alone, and surgical aortic valve replacement can improve symptoms and …

The development of transcatheter aortic valve implantation (TAVI) by our group has been a
20-year odyssey. In 1993, postmortem studies validated the concept of intravalvular stenting …

Over the past years, there has been a tremendous evolution of transcatheter aortic valve
implantation (TAVI) that turned a novel revolutionary approach to a mature concept. Peri …

Aortic stenosis is the most common type of valve disease in the adults. Until recently its
treatment was an exclusive domain of cardiac surgery. At the same time the aortic valve …

Aortic stenosis is the most commonly acquired valvular heart disease in the Western world.
Surgical aortic valve replacement is currently the gold-standard treatment for patients with …

Ttranscatheter aortic valve implantation (TAVI) is currently reserved for high surgical risk or
inoperable patients. In 2007, TAVI actually represented approximately 1.2% of all aortic …

Background Transcatheter aortic valve implantation (TAVI) has been adopted worldwide as
the standard treatment for severe aortic stenosis in symptomatic patients at prohibitive or …

Transcatheter aortic valve implantation (TAVI) is now increasingly performed, and 30,000
patients with severe aortic stenosis and contraindications to or high risk for surgery have …